On a 12-month basis, the trend at Uroplasty looks very good. At 46.0 days, it is 7.9 days better than the five-year average of 53.9 days. The biggest contributor to that improvement was DIO, which improved 21.8 days compared to the five-year average. That was partially offset by a 13.6-day increase in DPO.
Considering the numbers on a quarterly basis, the CCC trend at Uroplasty looks weak. At 57.5 days, it is 18.9 days worse than the average of the past eight quarters. Investors will want to keep an eye on this for the future to make sure it doesn't stray too far in the wrong direction. With quarterly CCC doing worse than average and the latest 12-month CCC coming in better, Uroplasty gets a mixed review in this cash-conversion checkup.